Volume 86 Issue 23 | p. 24 | Concentrates
Issue Date: June 9, 2008

Gen-Probe Trumps Solvay In Bid For Innogenetics

Department: Business

Gen-Probe, a developer of nucleic acid diagnostics for human disease, has launched a bid to acquire Innogenetics, a Belgian molecular diagnostics firm, for $334 million. The offer competes with a deal announced in April by Solvay to acquire Innogenetics for about $280 million. Solvay currently owns 7% of Innogenetics. A Gen-Probe acquisition would create the world's largest stand-alone molecular diagnostics company, with annual sales in excess of $500 million, according to Gen-Probe. A Solvay official tells C&EN that the company "is currently analyzing the new situation and evaluating all the options."

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment